-
PHONE: 1-866-918-6812
AAV-CAG-GFP (AAV Serotype 6)
Product Category: Pre-made recombinant AAV; AAV-CAG-GFP; AAV-CBA-GFP, AAV6-CAG-GFP; AAV6-CBA-GFP
Description: AAV6-CAG-GFP is a pre-packaged rAAV in serotype 6 (with capsid from AAV serotype 6 and 2xITR from AAV serotype 2) which over-expresses EGFP under CAG (also known as CBA) promoter. CAG promoter is a combination of the cytomegalovirus (CMV) early enhancer element and chicken beta-actin promoter for high levels of gene expression in mammalian expression vectors. Ready to use format.
Titer: >1E+13 VG/mL
Size: 30 µL (Std Pack)
Reconstitution Buffer: Sterile PBS supplemented with final 0.005% Pluronic F-68 and 200 mM NaCl
Infection Protocol: 
Vector Map:
CITATIONS
| Shipping Weight | 6 lbs |
|---|---|
| Unit Size | 30 µL at >10¹³ VG/mL, 10 µL at >10¹³ VG/mL |
Customers who bought this product also purchased…
- SL101444AAV-Syn-iCre (AAV Serotype 6)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
- SL100819AAV-GFP (AAV Serotype 5)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
- SL116357AAV-CAG-GFP (Serotype Myo2A)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
- SL100826AAV-GFP (AAV Serotype 6)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
- SL100268LV-CMV-GFP-Puro$468.00Add to cart This product has multiple variants. The options may be chosen on the product page
- SL100816AAV-CAG-GFP (AAV Serotype 2)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
- SL116004AAV-EF1α-GFP (AAV Serotype 6)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
Custom Service Solutions
Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.
Important updates waiting for you!
Enter your email address below and subscribe to our newsletter